Eli Lilly and Company News
Novartis Follows Eli Lilly with $1.4 Billion Gene Editing Pact
Precision BioSciences is developing gene editing tools with several potential advantages over CRISPR.
Cramer's Mad Money Recap 6/15: Powell Crushes it
Jim Cramer says the Fed action is great news for high-growth tech stocks, which should be among the first sectors to recover.
Cramer's Mad Money Recap 6/7: Target, Smucker, Eli Lilly
Jim Cramer says smart investing is as simple as buying growth stocks when interest rates begin to fall.
Stock Market Today - 6/6: Dow Ends Slightly Higher as Treasury Yields Top 3%; Amazon Gains After 20-for-1 Split
Solid jobs and manufacturing data are prompting bets on a so-called 'Goldilocks' outcome for U.S. stocks as the Fed looks to tame inflation without choking-off growth.
Eli Lilly Stock Gains On Impressive Data From Jardiance Diabetes Drug Trial
"These five-year results ... showing empagliflozin was associated with a decreased risk of hospitalization for heart failure and for death, are encouraging data for adults with type 2 diabetes," said co-lead investigator Dr. Elisabetta Patorno.
Breaking News
Micron Stock Tumbles On Grim Chip Sector Outlook After Q3 Earnings Beat
"We saw a significant reduction in near-term industry bit demand, primarily attributable to end demand weakness in consumer markets," said CEO Sanjay Mehrotra.
Tesla Q2 Deliveries In Focus Following Record Quarterly Stock Slump, China Shutdowns
Tesla will publish Q2 deliveries over the coming days following the biggest three-month decline on record for shares of the world's most-valuable carmaker.
Kohl's Stock Plunges As Retailer Scraps Franchise Group Sale Talks
"Given the environment and market volatility, the Board determined that it simply was not prudent to continue pursuing a deal," said chairman Peter Boneparth.
General Motors Stock Halted, Edge Higher After Detailing Q2 Chip Shortage Hit To Inventory
GM said chip shortages and supply chain snarls left nearly 100,000 vehicles unfinished over the second quarter.